keto and semaglutide & the Diet: Combined Benefits Risks What to Expect - The

The authors conclude: In the STEP TEENS trial, treatment with semaglutide 2.4 mg once weekly for 68 weeks was associated with a significant reduction of levels of the liver enzyme alanine aminotransferase compared with placebo. Dr Weghuber adds: Fatty liver disease is the most frequent liver disease in adolescents with no drug therapy currently available

Is increased antidepressant exposure a contributory factor to the obesity pandemic

Notably, the FDA approved the oral Wegovy pill, offering a convenient alternative for those preferring not to use injections

Understanding your individual metabolic and genetic predispositions can help you and your provider design a realistic long-term weight management strategy